Laboratorios Andrómaco has made Chile's medicines for more than eight decades — and since 2014 it has done so as part of one of Europe's largest private pharmaceutical groups, even as its shares continue to trade in Santiago for a dwindling public minority. Key Facts Full nameLaboratorios Andrómaco S.A. Ticker / exchangeANDROMACO.SN — Bolsa de Santiago (SN) HeadquartersSantiago, Chile SectorPharmaceuticals — generics & branded Employees~1,390 (2012 audited filing; current figure not published) Market value (market cap)Not published: see note below Yearly sales (revenue)Not published: see note below Net profitNot published: …
Company Intelligence — Institutional Access
This dossier is part of our Company Intelligence database.
Full profiles, exchange dossiers and the regional intelligence briefs are available to institutional subscribers. Professional from US$490/year, Corporate US$1,450, Institutional US$3,900.
See institutional access →Already a subscriber? Log in.
Part of LatAm Company Intelligence
This company profile belongs to The Rio Times' research on every listed company and exchange in Latin America and the Caribbean. Browse the full intelligence hub →
Read More from The Rio Times
The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →